|
| 36040901 | Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients. | PLoS One | 2022 |
| 33355200 | A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study. | Clin Cancer Res | 2021 |
| 34681945 | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases. | Int J Mol Sci | 2021 |
| 33225631 | Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study. | Arthritis Rheumatol | 2021 |
| 31676670 | Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma. | Clin Cancer Res | 2020 |
| 31851795 | Trial of Anifrolumab in Active Systemic Lupus Erythematosus. | N Engl J Med | 2020 |
| 30778251 | The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity. | Nat Immunol | 2019 |
| 29716923 | Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab. | Clin Cancer Res | 2018 |
| 30093454 | Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab. | Clin Cancer Res | 2018 |
| 29956883 | Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease. | Arthritis Rheumatol | 2018 |
| 28000522 | Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus. | Immunotherapy | 2017 |
| 28130918 | Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2017 |
| 28982197 | Distinct and common expression of receptors for inflammatory mediators in vagal nodose versus jugular capsaicin-sensitive/TRPV1-positive neurons detected by low input RNA sequencing. | PLoS One | 2017 |
| 28819706 | Generation of a functional humanized Delta-like ligand 4 transgenic mouse model. | Transgenic Res | 2017 |
| 27923825 | Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery. | Cancer Immunol Res | 2017 |
| 27093186 | Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer. | PLoS Genet | 2016 |
| 26556607 | In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage. | Arthritis Rheumatol | 2016 |
| 27798262 | Autoimmune manifestations in aged mice arise from early-life immune dysregulation. | Sci Transl Med | 2016 |
| 27226090 | Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease. | J Immunol | 2016 |
| 26257170 | Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species. | Cell Rep | 2015 |
| 28848849 | CD4+ T-Cell Profiles and Peripheral Blood Ex-Vivo Responses to T-Cell Directed Stimulation Delineate COPD Phenotypes. | Chronic Obstr Pulm Dis | 2015 |
| 26653219 | HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. | J Transl Med | 2015 |
| 26587322 | A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T cell receptor repertoire clonality. | Oncoimmunology | 2015 |
| 26348576 | Synergistic actions of blocking angiopoietin-2 and tumor necrosis factor-α in suppressing remodeling of blood vessels and lymphatics in airway inflammation. | Am J Pathol | 2015 |
| 23434567 | A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. | Ann Rheum Dis | 2014 |
| 25384217 | Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. | J Clin Invest | 2014 |
| 24757153 | Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies. | Arthritis Rheumatol | 2014 |
| 24571613 | Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma. | BMC Cancer | 2014 |
| 24289491 | MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. | Pigment Cell Melanoma Res | 2014 |
| 24431284 | The plasma cell signature in autoimmune disease. | Arthritis Rheumatol | 2014 |
| 23990866 | Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study. | PLoS One | 2013 |
| 24200637 | Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients. | Cancer Genet | 2013 |
| 21881594 | Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. | Genes Immun | 2012 |
| 22574157 | The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA. | PLoS One | 2012 |
| 22262795 | Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection. | J Infect Dis | 2012 |
| 21860416 | A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. | Oncogene | 2012 |
| 21803750 | Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. | Ann Rheum Dis | 2011 |
| 22046260 | Altered expression of insulin receptor isoforms in breast cancer. | PLoS One | 2011 |
| 19479852 | Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. | Arthritis Rheum | 2009 |
| 20948567 | Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus. | Hum Genomics Proteomics | 2009 |